Why J.P. Morgan is Diving into Life Sciences
Attractive valuations and the rapid pace of biomedical innovation make it an ideal time for the investment bank to seek deals in the space.
After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.